ilomastat has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, M; Hitaka, K; Kakinuma, H; Kamitani, M; Kato, Y; Kojima, N; Mima, M; Mitani, A; Nomura, Y; Nozoe, A; Ohkubo, M; Takeda, T; Takeuchi, T; Tamita, T; Toki, H | 1 |
1 other study(ies) available for ilomastat and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.
Topics: Animals; Fibrosis; Idiopathic Pulmonary Fibrosis; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Zinc | 2022 |